Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases ; volume:9 ; number:1 ; day:16 ; month:2 ; year:2024 ; pages:1-53 ; date:12.2024
Signal transduction and targeted therapy ; 9, Heft 1 (16.2.2024), 1-53, 12.2024
- Urheber
-
Loh, Jian Sheng
Mak, Wen Qi
Tan, Li Kar Stella
Ng, Chu Xin
Chan, Hong Hao
Yeow, Shiau Hueh
Foo, Jhi Biau
Ong, Yong Sze
How, Chee Wun
Khaw, Kooi Yeong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41392-024-01743-1
- URN
-
urn:nbn:de:101:1-2024041510135155871783
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Loh, Jian Sheng
- Mak, Wen Qi
- Tan, Li Kar Stella
- Ng, Chu Xin
- Chan, Hong Hao
- Yeow, Shiau Hueh
- Foo, Jhi Biau
- Ong, Yong Sze
- How, Chee Wun
- Khaw, Kooi Yeong
- SpringerLink (Online service)
Ähnliche Objekte (12)
The complex relationship between the microbiota-gut-brain axis and neurodegenerative diseases and future perspectives
PERK: a novel therapeutic target for neurodegenerative diseases?
Neurodegenerative diseases
Neurodegenerative diseases
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases
The complex relationship between the microbiota-gut-brain axis and neurodegenerative diseases and future perspectives
PERK: a novel therapeutic target for neurodegenerative diseases?
Neurodegenerative diseases
Neurodegenerative diseases
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases
The complex relationship between the microbiota-gut-brain axis and neurodegenerative diseases and future perspectives
PERK: a novel therapeutic target for neurodegenerative diseases?
Neurodegenerative diseases
Neurodegenerative diseases
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies